s.zielinski
Submits third-party assay reports on material purchased directly. Based in Breda.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.90%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042531 | TB-500 | HJ | HJ-2511-V5472 | Janoshik | 2026-Q1 | 99.70 | 6.91 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019263 | GHRP-6 | AMB | AMB-2508-T5301 | Janoshik | 2025-Q3 | 99.44 | 5.22 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020539 | Vilon | SSA | SSA-2508-B6436 | Nordanalyt | 2025-Q3 | 99.26 | 5.49 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-021069 | Hexarelin | BCH | BCH-2501-B4807 | PeptideMeter | 2025-Q2 | 97.69 | 5.98 | 91.4 | Buyer-sourced | 0 | FAIL |
| AX-2025-020863 | MK-677 (Ibutamoren mesylate) | CPC | CPC-2503-G2382 | Janoshik | 2025-Q2 | 98.53 | 5.54 | 97.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-018506 | Semaglutide | WWB | WWB-2501-K3141 | Nordanalyt | 2025-Q1 | 98.43 | 4.13 | — | Buyer-sourced | 1 | MARGINAL |